Awards granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Document Type Document Type Outstanding, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Other income, net Other Nonoperating Income (Expense) Common stock Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract] Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Innovatus Life Sciences Lending Fund Innovatus Life Sciences Lending Fund [Member] Innovatus Life Sciences Lending Fund Awards released/ Weighted-Average Grant Date Fair Value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Level 3 Fair Value, Inputs, Level 3 [Member] Rental Property, by Type [Axis] Rental Property, by Type [Axis] Rental Property, by Type Schedule of Outstanding Warrants Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Statistical Measurement [Domain] Statistical Measurement [Domain] Liabilities and Stockholders' Equity Liabilities and Equity [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Deferred tax liabilities Deferred Income Tax Liabilities, Net Security Exchange Name Security Exchange Name Covid-19 Coronavirus, Aid, Relief, And Economic Securities (CARES) Act Disclosure [Text Block] Coronavirus, Aid, Relief, And Economic Securities (CARES) Act Disclosure Term loan borrowings Proceeds from Issuance of Long-term Debt Loss from operations Operating Income (Loss) Blue Shield Blue Shield [Member] Blue Shield Total current liabilities Liabilities, Current Other Other Customer [Member] Prepaid and other current assets Prepaid Expense and Other Assets, Current Outstanding, December 31, 2020 (in dollars per share) Outstanding, March 31, 2021 (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Royalty obligation, percent of net sales Royalty Obligation, Percentage of Sales Royalty Obligation, Percentage of Sales Commitments and contingencies Commitments and Contingencies Assets Assets [Abstract] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Stock options, vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Accounting Policies [Abstract] Furniture and fixtures Furniture and Fixtures [Member] Entity Address, State or Province Entity Address, State or Province Awards released (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Proceeds from common stock issued under Employee Stock Purchase Pan Proceeds from Stock Plans Accounts payable Accounts Payable, Current 2024 Long-Term Debt, Maturity, Year Three Coronavirus, Aid, Relief, And Economic Securities (CARES) Act, deferred tax assets, valuation allowance Coronavirus, Aid, Relief, And Economic Securities (CARES) Act, Deferred Tax Assets, Valuation Allowance Coronavirus, Aid, Relief, And Economic Securities (CARES) Act, Deferred Tax Assets, Valuation Allowance Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Product Concentration Risk Product Concentration Risk [Member] Outstanding, December 31, 2020 (in shares) Outstanding, March 31, 2021 (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Schedule of Fair Value, Financial Instrument Measured on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Stock options, unrecognized compensation cost Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Customer [Axis] Customer [Axis] Operating lease, renewal term Operating Leases, Renewal Term Operating Leases, Renewal Term Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued or outstanding at March 31, 2021 and December 31, 2020 Preferred Stock, Value, Issued Accrued purchases of goods and services Accrued Purchase, Goods and Services, Current Accrued Purchase, Goods and Services, Current Par value (in dollars per share) Common Stock, Par or Stated Value Per Share Other non-current liabilities Other Liabilities, Noncurrent Stock-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition Rental Property, by Type [Domain] Rental Property, by Type [Domain] Rental Property, by Type Revenue Revenue from Contract with Customer, Excluding Assessed Tax Measurement Frequency [Domain] Measurement Frequency [Domain] Term loan, paid in-kind loans issued Debt Instrument, Paid In Kind Loans Issued Debt Instrument, Paid In Kind Loans Issued Advertising expense Advertising Expense Lender Name [Axis] Lender Name [Axis] Warrant expiration September 7, 2024 Expiration Sep 7, 2024 [Member] Expiration Sep 7, 2024 Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract] Percent of total revenue Concentration Risk, Percentage Stock options, expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Joint venture, quarterly promotion fee Joint Venture, Quarterly Promotion Fee Joint Venture, Quarterly Promotion Fee Statement [Line Items] Statement [Line Items] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Forecast Forecast [Member] Office Office [Member] Office Debt instrument, term Debt Instrument, Term Accrued interest Interest Payable, Current Warrant expiration March 31, 2026 Expiration Mar 31, 2026 [Member] Expiration Mar 31, 2026 Initial license fee License Agreement, Initial License Fee License Agreement, Initial License Fee Statement [Table] Statement [Table] Statistical Measurement [Axis] Statistical Measurement [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Shares issued (in shares) Preferred Stock, Shares Issued Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Expected volatility rate, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Class of warrant or right, exercise price of warrants or rights (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Net loss per share, basic and diluted (USD per share) Earnings Per Share, Basic and Diluted Entity Small Business Entity Small Business Medicare Medicare [Member] Medicare Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Initial public offering (in shares) Sale of Stock, Number of Shares Issued in Transaction Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Borrowings Debt Disclosure [Text Block] Proceeds from the issuance of common stock in public offering, gross Proceeds from Issuance of Common Stock Cost of revenue Cost of Revenue Selling, general and administrative Selling, General and Administrative Expenses [Member] Amendment Flag Amendment Flag Joint venture quarterly promotion fee cap Joint Venture, Quarterly Promotion Fee, Capped Amount, Percentage Above Baseline Joint Venture, Quarterly Promotion Fee, Capped Amount, Percentage Above Baseline Warrant expiration December 7, 2025 Expiration Dec 7, 2025 [Member] Expiration Dec 7, 2025 Research and Development Research and Development Expense, Policy [Policy Text Block] Shares that remain available for future awards (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Other accrued liabilities Other Accrued Liabilities, Current Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Current Other Assets Increase (Decrease) in Prepaid Expense and Current Other Assets Accounts Receivable Receivable Benchmark [Member] Receivable Benchmark Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Entity Central Index Key Entity Central Index Key Measurement Frequency [Axis] Measurement Frequency [Axis] Financial Instruments [Domain] Financial Instruments [Domain] United Healthcare United Healthcare [Member] United Healthcare Costs incurred, but not paid, in connection with capital expenditures Capital Expenditures Incurred but Not yet Paid Equipment purchased under capital lease obligations Equipment Purchased Under Capital Lease Equipment Purchased Under Capital Lease Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] 2025 Long-Term Debt, Maturity, Year Four Loss before income taxes Income (Loss) Attributable to Parent, before Tax Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Employee stock purchase plan Employee Stock [Member] Income Statement Location [Axis] Income Statement Location [Axis] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Income Statement Location [Domain] Income Statement Location [Domain] Selling, general and administrative expenses Selling, General and Administrative Expense Prepaid expenses table Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Other assets Other Assets, Noncurrent Plan Name [Axis] Plan Name [Axis] Prometheus Laboratories Prometheus Laboratories, Inc. [Member] Prometheus Laboratories, Inc. Issuance of stock in public offering, net of issuance costs of $4,435 Stock Issued During Period, Value, New Issues Money market funds, included in cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Total assets Assets Scenario [Axis] Scenario [Axis] 2019 Incentive Award Plan Incentive Award Plan, 2019 [Member] Incentive Award Plan, 2019 Organization Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Outstanding, December 31, 2020 (in shares) Outstanding, March 31, 2021 (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Title of 12(b) Security Title of 12(b) Security Accrued and other current liabilities Schedule of Accrued Liabilities [Table Text Block] Interest Long-term Debt, Undiscounted Interest Amount Long-term Debt, Undiscounted Interest Amount Subsequent Event Type [Axis] Subsequent Event Type [Axis] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Cost of revenue Cost of Sales [Member] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Concentration of Credit Risk and Other Risk and Uncertainties Concentration Risk, Credit Risk, Policy [Policy Text Block] Interest expense Interest Expense Proceeds from public offering, net Sale of Stock, Consideration Received on Transaction Depreciation and amortization Depreciation, Depletion and Amortization Product and Service [Axis] Product and Service [Axis] Total liabilities Liabilities Term loan, paid in-kind, interest rate Debt Instrument, Stated Interest Rate, Paid In-Kind Debt Instrument, Stated Interest Rate, Paid In-Kind Stock options, cost not yet recognized, remaining weighted average vesting period Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Supplemental disclosure of non-cash items: Supplemental Cash Flow Elements [Abstract] Vested and expected to vest, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 2023 Long-Term Debt, Maturity, Year Two Commitments and Contingencies Disclosure [Abstract] Level 1 Fair Value, Inputs, Level 1 [Member] Options exercisable, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Accounts payable Increase (Decrease) in Accounts Payable Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Outstanding, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Capital lease obligations, current portion Capital Lease Obligations, Current Debt Instrument [Axis] Debt Instrument [Axis] Additional Paid-In Capital Additional Paid-in Capital [Member] Prepaid maintenance and insurance contracts Prepaid Maintenance and Insurance Contracts Prepaid Maintenance and Insurance Contracts New Accounting Pronouncement, Early Adoption [Table] New Accounting Pronouncement, Early Adoption [Table] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Class of Stock [Line Items] Class of Stock [Line Items] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Licensing Agreements License Agreement Terms [Member] Options exercised, March 31, 2021, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Research and development expenses Research and Development Expense IPO IPO [Member] Subsequent Event Subsequent Event [Member] Joint venture, number of units prescribed quarterly Joint Venture, Quarterly Prescribed Units Joint Venture, Quarterly Prescribed Units Outstanding, December 31, 2020, Weighted Average Exercise Price (in dollars per share) Outstanding, March 31, 2021, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Shares authorized (in shares) Common Stock, Shares Authorized Schedule of Restricted Stock Unit Activity Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Healthcare insurers Healthcare Insurers [Member] Healthcare Insurers Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total property and equipment Property and equipment, gross Property, Plant and Equipment, Gross Proceeds from exercise of stock options Proceeds from Stock Options Exercised Revenue Recognition Revenue [Policy Text Block] Office and Laboratory Office and Laboratory [Member] Office and Laboratory Income Statement [Abstract] Income Statement [Abstract] Operating lease, rent expense Operating Leases, Rent Expense Accrued royalties Accrued Royalties, Current Unamortized debt discount and issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Current assets: Assets, Current [Abstract] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Net exercise of common stock warrants (in shares) Stock Issued During Period, Shares, Warrants Exercised, Net Stock Issued During Period, Shares, Warrants Exercised, Net Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share 2022 Long-Term Debt, Maturity, Year One Scenario [Domain] Scenario [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment City Area Code City Area Code Computer equipment and software Computer Equipment and Software [Member] Computer Equipment and Software Joint venture, quarterly promotion fee per prescription Joint Venture, Quarterly Promotion Fee Per Prescription Joint Venture, Quarterly Promotion Fee Per Prescription Document Period End Date Document Period End Date Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Stock-based compensation Share-based Payment Arrangement, Noncash Expense 2021 (remaining) Long-Term Debt, Maturity, Remainder of Fiscal Year Cover [Abstract] Allegheny Health Network Research Institute Allegheny Health Network Research Institute [Member] Allegheny Health Network Research Institute Loan payable Loans Payable [Member] Total borrowings, net of discounts and debt issuance costs Long-term Debt Fair Value Disclosures [Abstract] 2017 Term loan Term 2017 [Member] Term 2017 Reorganizations [Abstract] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Costs of revenue Cost of Goods and Services Sold Depreciation and amortization Cost, Depreciation and Amortization Total operating expenses Costs and Expenses Equity Components [Axis] Equity Components [Axis] Co-promotion agreement, renewal term Co-Promotion Agreement, Renewal Term Co-Promotion Agreement, Renewal Term Share-based Payment Arrangement [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Minimum Minimum [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Assets under capital lease Assets Under Capital Lease [Member] Assets Under Capital Lease Awards canceled/Weighted-Average Grant Date Fair Value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Schedule of Fair Value Assumptions, Stock Options Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Accrued payroll and related expenses Accrued Salaries, Current Entity Interactive Data Current Entity Interactive Data Current Exercised, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Schedule of Restricted Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Schedule of Stock Option Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Customer [Domain] Customer [Domain] Issuance costs included in accounts payable and accrued liabilities Deferred Offering Costs Included within Current Liabilities Deferred Offering Costs Included within Current Liabilities Entity Registrant Name Entity Registrant Name Subsequent Event Type [Domain] Subsequent Event Type [Domain] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Assets: Assets, Fair Value Disclosure [Abstract] Term loan, fee incurred upon payment of final installment Debt Instrument, Fee Amount Options exercisable, March 31, 2021 (in Shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Advertising and Marketing Costs Advertising Cost [Policy Text Block] Shipping and Handling Shipping and Handling [Member] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Paid in-kind note Payment in Kind (PIK) Note [Member] Term loan, effective interest rate Debt Instrument, Interest Rate, Effective Percentage Research and development Research and Development Expense [Member] Purchase obligation, to be paid remainder of fiscal year Purchase Obligation, to be Paid, Remainder of Fiscal Year Non-cash interest expense Paid-in-Kind Interest Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Risk-free interest rate, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Sale of Stock [Axis] Sale of Stock [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Weighted-average number of shares used to compute net loss per share, basic and diluted (in shares) Weighted Average Number of Shares Outstanding, Basic and Diluted Other prepaid and other current assets Other Prepaid Expense, Current Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Goodwill Goodwill Document Transition Report Document Transition Report Schedule of Fair Value Assumptions, Employee Stock Purchase Plan Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Capital Royalty Partners II LP Capital Royalty Partners II LP [Member] Capital Royalty Partners II LP Term loan covenant, minimum unrestricted cash balance Debt Instrument, Covenant Compliance, Minimum Unrestricted Cash Balance Debt Instrument, Covenant Compliance, Minimum Unrestricted Cash Balance Warrants issued to purchase redeemable convertible preferred stock (in shares) Class of Warrant or Right, Outstanding Warrants to purchase common stock Warrant [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Diagnostic testing supplies Other Assets, Current Document Quarterly Report Document Quarterly Report Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Equity [Abstract] Granted, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Customer Concentration Risk Customer Concentration Risk [Member] Vested and expected to vest, March 31, 2021 (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Government Government1 [Member] Government1 Expected term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Number of operating segments Number of Operating Segments Entity File Number Entity File Number Awards canceled (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Debt Disclosure [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Amortization of debt discount and debt issuance costs Amortization of Debt Issuance Costs and Discounts Loan repayment Repayments of Long-term Debt Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Options exercisable, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Stock-based compensation expense Share-based Payment Arrangement, Expense Balance Sheet Location [Axis] Balance Sheet Location [Axis] Issuance of stock under Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan Counterparty Name [Axis] Counterparty Name [Axis] Common stock, $0.001 par value; 200,000,000 shares authorized at March 31, 2021 and December 31, 2020; 16,925,680 and 12,652,308 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively Common Stock, Value, Issued Other Financial Information Prepaid Expenses and Other Current Assets; Property, Plant and Equipment; and Accrued Liabilities [Text Block] Prepaid Expenses and Other Current Assets; Property, Plant and Equipment; and Accrued Liabilities Document Fiscal Year Focus Document Fiscal Year Focus Entity Current Reporting Status Entity Current Reporting Status Shares issued in public offering, price per share (in dollars per share) Sale of Stock, Price Per Share Prepaid product royalties Prepaid Royalties Principal payment on capital lease obligations Repayments of Long-term Capital Lease Obligations Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Awards granted, Weighted-Average Grant Date Fair Value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Medicare Advantage Medicare Advantage [Member] Medicare Advantage Shares issued (in shares) Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Borrowings-non-current portion, net of discounts and debt issuance costs Long-term Debt, Excluding Current Maturities Term loan, prepayment premium percentage Debt Instrument, Prepayment Premium Percentage Debt Instrument, Prepayment Premium Percentage Accounts receivable, net Increase (Decrease) in Accounts Receivable Debt Instrument [Line Items] Debt Instrument [Line Items] Total stockholders' equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Payment of issuance costs related to public offering Payments of Stock Issuance Costs Concentration Risk Type [Domain] Concentration Risk Type [Domain] Total liabilities and stockholders' equity Liabilities and Equity Loss Contingencies [Line Items] Loss Contingencies [Line Items] Entity Address, City or Town Entity Address, City or Town Schedule of Concentration of Risk, by Risk Factor and Significant Payer Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Restricted stock units Restricted Stock Units (RSUs) [Member] Maximum employee payroll deduction percentage Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate Remaining milestone obligation Milestone Obligation Milestone Obligation Other assets Other Assets [Member] Financial Instrument [Axis] Financial Instrument [Axis] Advance royalties payment Advance Payment Advance Payment Anti-dilutive securities excluded from computation (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Co-Promotion Agreement, Period Before Current Expiration To Extend Term Co-Promotion Agreement, Period Before Current Expiration To Extend Term Co-Promotion Agreement, Period Before Current Expiration To Extend Term Entity Ex Transition Period Entity Ex Transition Period Equity Component [Domain] Equity Component [Domain] Other assets Increase (Decrease) in Other Noncurrent Assets Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Construction in progress Construction in Progress [Member] Entity Tax Identification Number Entity Tax Identification Number Janssen (SIMPONI) Janssen (SIMPONI) [Member] Janssen (SIMPONI) Stock Option Plan Share-based Payment Arrangement [Text Block] Net loss Net loss Net Income (Loss) Attributable to Parent Changes in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Co-promotion, number of days' noticed required to give to terminate agreement Co-Promotion Agreement, Number Of Days' Notice To Terminate Agreement Co-Promotion Agreement, Number Of Days' Notice To Terminate Agreement AVISE CTD Test AVISE CTD Test [Member] AVISE CTD Test Laboratory equipment Laboratory Equipment [Member] Laboratory Equipment Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Total current assets Assets, Current Current Fiscal Year End Date Current Fiscal Year End Date Warrant expiration January 19, 2026 Expiration Jan 19, 2026 [Member] Expiration Jan 19, 2026 Stockholders' equity: Stockholders' Equity Attributable to Parent [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Document Fiscal Period Focus Document Fiscal Period Focus Term loan, annual reduction in prepayment penalty percentage Debt Instrument, Prepayment Premium Percentage, Annual Reduction Debt Instrument, Prepayment Premium Percentage, Annual Reduction Accrued clinical study activity Accrued Liabilities, Clinical Study, Current Accrued Liabilities, Clinical Study, Current Supplier Concentration Risk Supplier Concentration Risk [Member] Supplemental disclosure of cash flow information: Supplemental Cash Flow Information [Abstract] Term loan covenant, increase to interest rate Debt Instrument, Covenant Non-Compliance, Interest Rate, Increase (Decrease) Debt Instrument, Covenant Non-Compliance, Interest Rate, Increase (Decrease) Issuance of stock under Employee Stock Purchase Plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Entity Filer Category Entity Filer Category Schedule of Non-cash Stock-based Compensation Expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Common Stock Common Stock [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Product and Service [Domain] Product and Service [Domain] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Future minimum royalty commitment Royalty Guarantees, Commitments, Amount Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Risk-free interest rate, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Client Client [Member] Client Property and equipment Property, Plant and Equipment [Table Text Block] Coronavirus, Aid, Relief, And Economic Securities (CARES) Act, deferred tax assets, income tax benefit Coronavirus, Aid, Relief, And Economic Securities (CARES) Act, Deferred Tax Assets, Income Tax Benefit Coronavirus, Aid, Relief, And Economic Securities (CARES) Act, Deferred Tax Assets, Income Tax Benefit Issuance of stock in public offering, net of issuance costs of $4,435 (in shares) Stock Issued During Period, Shares, New Issues Leasehold improvements Leasehold Improvements [Member] Revenue Benchmark Revenue Benchmark [Member] New Accounting Pronouncement, Early Adoption [Line Items] New Accounting Pronouncement, Early Adoption [Line Items] Term loan, interest rate Debt Instrument, Interest Rate, Stated Percentage Money market funds, included in cash and cash equivalents Money Market Funds [Member] Annual increase in purchase commitments Purchase Obligation, Annual Increase In Commitment, Percentage Purchase Obligation, Annual Increase In Commitment, Percentage Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Vested and expected to vest, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Exercise of stock options (in shares) Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Deferred offering costs reclassified to equity Deferred Offering Costs Reclassified to Equity Deferred Offering Costs Reclassified to Equity Net change in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Total Long-term Debt, Including Undiscounted Interest Long-term Debt, Including Undiscounted Interest Stock options Share-based Payment Arrangement, Option [Member] Collaboration fee Collaboration Agreement, Annual Collaboration Fee Collaboration Agreement, Annual Collaboration Fee Other Financial Information [Abstract] Other Financial Information Stock-Based Compensation Employee Stock Ownership Plan (ESOP), Policy [Policy Text Block] Preferred stock Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract] Operating expenses: Costs and Expenses [Abstract] Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Forfeited, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Accrued and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Sale of Stock [Domain] Sale of Stock [Domain] Loss Contingencies [Table] Loss Contingencies [Table] Plan Name [Domain] Plan Name [Domain] Cash paid for interest expense Interest Paid, Excluding Capitalized Interest, Operating Activities Common stock options Equity Option [Member] Expected volatility rate, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Additional paid-in capital Additional Paid in Capital Cash, Cash Equivalents and Restricted Cash Cash and Cash Equivalents, Policy [Policy Text Block] Income tax benefit Income Tax Expense (Benefit) Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents and restricted cash, end of period Total Cash, Cash Equivalents and Restricted Cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Schedule of Future Minimum Aggregate Payments for Outstanding Borrowings Schedule of Maturities of Long-term Debt [Table Text Block] Accrued and other current liabilities Accrued and other current liabilities Accrued Liabilities, Current Local Phone Number Local Phone Number Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Entity Address, Address Line One Entity Address, Address Line One Entity Emerging Growth Company Entity Emerging Growth Company Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Deferred income taxes Deferred Income Tax Expense (Benefit) Warrant expiration April 1, 2026 Expiration Apr 1, 2026 [Member] Expiration Apr 1, 2026 Award Type [Axis] Award Type [Axis] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Prepaid expenses and other current assets Prepaid Expense and Other Assets Maximum Maximum [Member] Shares authorized (in shares) Preferred Stock, Shares Authorized Purchase obligation, due in year one Purchase Obligation, to be Paid, Year One Restricted cash Restricted Cash Accumulated Deficit Retained Earnings [Member] Shares outstanding (in shares) Preferred Stock, Shares Outstanding Stock issuance costs Estimated offering expenses for aggregate expenses Stock Issuance Costs Stock Issuance Costs Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Stock Options, Additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Domain] Award Type [Domain] Trading Symbol Trading Symbol Remaining milestone obligation, fair value Milestone Contingency, Fair Value Disclosure Milestone Contingency, Fair Value Disclosure Net exercise of common stock warrants Stock Issued During Period, Value, Warrants Exercised, Net Stock Issued During Period, Value, Warrants Exercised, Net Organization, Consolidation and Presentation of Financial Statements [Abstract] Current liabilities: Liabilities, Current [Abstract] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Entity Shell Company Entity Shell Company Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Recurring Fair Value, Recurring [Member] Vested and expected to vest, March 31, 2021, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Segment Reporting Segment Reporting, Policy [Policy Text Block] Expired, Weighted Average Exercise Price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Recent Accounting Pronouncements Not Yet Adopted; Recently Adopted Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract]